On the recordMarch 11, 2020
Madam President, I am going to speak about the drug affordability act, what people in Washington call the Grassley-Wyden bill. I am renaming that bill. I am going to rename that bill to what I call the ``Making Coronavirus Medicines Affordable Act,'' and I want to address drug affordability from the perspective of coronavirus and address it from the perspective of a physician. First, people ask: How is this different than regular flu? Ten thousand people die a year from flu. Why is this so different from that? Well, again, as a physician, let me speak to that. Each of us, however old we are, have been exposed to flu, either by the flu vaccine or a flu infection, as many years as we have been alive. So when someone is exposed to the flu, they have a whole kind of armamentarium of antibodies. When the flu virus comes into your body, those antibodies mobilize, and it is not an exact fit to block the effects of the flu virus, but it is a pretty good fit. So for an infection which otherwise might cause problems, the effect is blunted and the symptoms are either absent or minimized. As it turns out, the flu virus kills the very young, who have never before been exposed to the flu virus before, or the very old, whose immune systems are no longer working as well. Even though they have been previously exposed, their body is more vulnerable. Now, as for coronavirus, nobody's body has ever seen that before.…





